Dual L/N-Type Ca2+ Channel Blocker: Cilnidipine as a New Type of Antihypertensive Drug

QR Code

Dual L/N-Type Ca2+ Channel Blocker: Cilnidipine as a New Type of Antihypertensive Drug

None

Saved in:

Bibliographic Details
Main Author:	Takahara, Akira
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/34158
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antihypertension drugs in prevention of cognition disorder and dementia: focus on calcium channel blockers and diuretics
by: O. D. Ostroumova, et al.
Published: (2018-10-01)

L-type calcium channel blockers at therapeutic concentrations are not linked to CRAC channels and heart failure
by: Gary S. Bird, et al.
Published: (2025-12-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

Computational Screening of Heterocyclic L-Type Calcium Channel Blockers for Potential Anti-Parkinson’s Activity
by: Thomas Kurian, et al.
Published: (2025-03-01)

L-Type Ca2+ Current in Cardiac Arrhythmias
by: Ruiz-Hurtado, Gema, et al.
Published: (2012)

Antihypertensive Treatment in Type 2 Diabetic Patients
by: Carella, Angelo Michele
Published: (2011)

Selection of antihypertensive therapy in elderly patients, combination therapy: thiazide-like diuretics and calcium channel blockers
by: z. M. Galeyeva, et al.
Published: (2018-12-01)

COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION
by: S. A. Boitsov, et al.
Published: (2016-01-01)

Dual-targeted N-PMIplus@CA nanoplatform for concurrent MDM2 and β-catenin inhibition in p53 wild-type lung adenocarcinoma
by: Ni Zhao, et al.
Published: (2025-10-01)

METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES
by: M. E. Statsenko, et al.
Published: (2015-09-01)

Effects of T-type calcium channel blockers on renal function and aldosterone in patients with hypertension: a systematic review and meta-analysis.
by: Xue Li, et al.
Published: (2014-01-01)

Sodium Channel Blockers for Vestibular Paroxysmia in Children
by: Pierre Reynard, et al.
Published: (2025-06-01)

Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
by: M. A. Maksimova, et al.
Published: (2015-09-01)

Сardioprotective agents with biaromatic structure. Part 2. HCN channel blockers
by: G. V. Mokrov
Published: (2022-07-01)

Pharmaceutical and non-pharmaceutical antihypertensive therapy in Type 2 diabetes mellitus patients
by: S. G. Malishevsky
Published: (2006-04-01)

High-Dose Insulin Euglycemic Therapy in Concomitant Beta-Blocker and Calcium Channel Blocker Overdose
by: Varun Roperia MD, et al.
Published: (2025-07-01)

POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK
by: Z M. Sizova
Published: (2015-09-01)

Vascular endothelium state in different types of antihypertensive treatment
by: N. V. Kucherenko, et al.
Published: (2008-02-01)

Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers?
by: V. V. Fomin, et al.
Published: (2007-06-01)

The Method of Types for the AWGN Channel
by: Sergey Tridenski, et al.
Published: (2025-06-01)

Beta-blocker and calcium-channel blocker therapy in patients with cardiovascular pathologies during post-COVID period
by: A. G. Arutyunov, et al.
Published: (2022-01-01)

Algorithm for differential administration of combination antihypertensive therapy in patients with Type 2 diabetes mellitus
by: O. A. Koshelskaya, et al.
Published: (2013-08-01)

Efficacy of insulin therapy in severe poisoning with calcium channel blockers
by: A. Yu. Simonova, et al.
Published: (2023-12-01)

COMBINATION ANTIHYPERTENSION THERAPY: TRIPLE FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS
by: O. D. Ostroumova, et al.
Published: (2017-02-01)

ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2015-09-01)

Development of the channel type centrifugal pump
by: A. P. Kuleshov, et al.
Published: (2018-09-01)

Impaired Vascular BK Channel Function in Type 2 Diabetes Mellitus
by: Lu, Tong, et al.
Published: (2011)

TREATMENT OF ESSENTIAL HYPERTENSION WITH CALCIUM CHANNEL BLOCKERS: WHAT IS THE PLACE OF LERCANIDIPINE
by: Michel Burnier, et al.
Published: (2010-04-01)

A Modern View on the Treatment for Acute Calcium Channel Blocker Poisoning
by: A. Yu. Simonova, et al.
Published: (2024-09-01)

Therapeutic Potential of Calcium Channel Blockers in Neuropsychiatric, Endocrine and Pain Disorders
by: Aarish Manzar, et al.
Published: (2025-07-01)

POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY
by: Yu. V. Lukina, et al.
Published: (2016-01-01)

COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

THE IMPACT OF THIRD-GENERATION BETA-BLOCKER ANTIHYPERTENSIVE TREATMENT ON ENDOTHELIAL FUNCTION AND THE PROTHROMBOTIC STATUS. EFFECTS OF SMOKING
by: G. P. Vyssoulis, et al.
Published: (2011-04-01)

Genetic polymorphism and pharmacokinetics of antihypertensive drugs
by: Nicolae Bacinschi, et al.
Published: (2025-01-01)

Hypertension and Headache: the Effect of Antihypertensive Drugs
by: V. A. Parfenov, et al.
Published: (2019-07-01)

Hypertension in pregnancy: use of antihypertensive drugs
by: Tore Henriksen
Published: (1997-02-01)

Experimental modeling of sudden death pathological mechanisms in Na+ channel blocker treatment
by: V. M. Moroz, et al.
Published: (2006-06-01)

Сardioprotective agents with biaromatic structure. Part 1. Calcium channel blockers
by: G. V. Mokrov
Published: (2022-02-01)

Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers
by: G. V. Mokrov
Published: (2022-12-01)